Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-000879
Filing Date
2025-01-06
Accepted
2025-01-06 19:00:33
Documents
1
Period of Report
2025-01-02

Document Format Files

Seq Description Document Type Size
1 form4-01062025_070130.html 4  
1 form4-01062025_070130.xml 4 4230
  Complete submission text file 0001415889-25-000879.txt   5710
Mailing Address 6005 HIDDEN VALLEY ROAD SUITE 110 CARLSBAD CA 92011
Business Address 6005 HIDDEN VALLEY ROAD SUITE 110 CARLSBAD CA 92011 858-293-4900
Design Therapeutics, Inc. (Issuer) CIK: 0001807120 (see all company filings)

EIN.: 823929248 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O DESIGN THERAPEUTICS, INC. 6005 HIDDEN VALLEY ROAD, SUITE 110 CARLSBAD CA 92011
Business Address
Burgess Julie (Reporting) CIK: 0001883722 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40288 | Film No.: 25512917